CAES for Internal Hemorrhoids and Rectal Prolapse
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFaming Zhang
About this trial
Cap-assisted endoscopic sclerotherapy (CAES) is a new interventional therapy for internal hemorrhoids and rectal prolapse under colonoscopy. However, the long-term efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse are still not clear due to the lack of large sample studies. Therefore, a nationwide multi-center, large sample, prospective and cohort study was designed to evaluate the efficacy and safety of CAES in the treatment of internal hemorrhoids and rectal prolapse, to provide reliable evidence for popularization of this minimally invasive technology.
Eligibility criteria
Qualifiers
Grade I-III internal hemorrhoids (with or without external hemorrhoids) or/and recal prolapse.
Patients with bowel preparation.
Disqualifiers
History of anoscopic/endoscopic sclerotherapy.
Acute thrombotic hemorrhoids or grade IV internal hemorrhoids.
Anal stenosis, perianal and perirectal abscess, anal fissure, fistula, fecal incontinence and other severe complications (such as severe anal pain).
Inflammatory bowel disease.
Trial design
Treatments tested in this trial
- Cap-assisted endoscopic sclerotherapy
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Faming Zhang
Lead sponsor
The Second Hospital of Nanjing Medical University
Sponsor institution
Source ClinicalTrials.gov